Literature DB >> 1514059

Specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus following immunization.

A S Kaniuk1, J E Lortan, M A Monteil.   

Abstract

Complement and specific antibody directed against capsular polysaccharide are necessary for efficient phagocytosis of pneumococci. In normal adults, specific antibody to pneumococci is predominantly of the IgG2 subclass. However, the role of IgG2 in bacterial clearance is debatable. We therefore decided to investigate the relationship between specific IgG subclass antibody levels and phagocytosis of serotype 14 pneumococcus, before and after immunization with a pneumococcal capsular polysaccharide vaccine. Specific IgG subclass antibody was measured by an ELISA technique and the effect of serum on phagocytosis of radiolabelled pneumococci by normal polymorphs was determined. We found that in the presence of complement, phagocytosis correlated significantly with both specific IgG1 and IgG2 antibody titres (r = 0.547, P = 0.002 and r = 0.464, P = 0.009, respectively). However, in decomplemented sera, the correlation with IgG1 antibody was lost, whereas that with IgG2 antibody was strengthened (r = 0.641, P = less than 0.001). The possibility that IgG2 binds to receptors on polymorphs should be considered.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514059     DOI: 10.1111/j.1365-3083.1992.tb01628.x

Source DB:  PubMed          Journal:  Scand J Immunol Suppl        ISSN: 0301-6323


  8 in total

1.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients.

Authors:  S M Quinn; J B Zhang; J C Gunsolley; J G Schenkein; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.

Authors:  J E Martinez; S Romero-Steiner; T Pilishvili; S Barnard; J Schinsky; D Goldblatt; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.

Authors:  Markus A Rose; Ralf Schubert; Nicola Strnad; Stefan Zielen
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

5.  Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.

Authors:  A Nowak-Wegrzyn; J A Winkelstein; A J Swift; H M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 6.  Use of licensed vaccines for active immunization of the immunocompromised host.

Authors:  L A Pirofski; A Casadevall
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Authors:  M A Shelly; H Jacoby; G J Riley; B T Graves; M Pichichero; J J Treanor
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

8.  Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.

Authors:  B T Carvalho; M M Carneiro-Sampaio; D Solé; C Naspitz; L E Leiva; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  1999-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.